Short-course fluoroquinolone treatment is as effective as the conventional 7-day course for acute exacerbations of chronic ...

According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

As per the agreement, SUP will obtain regulatory approvals for selling Tiotropium DPI in China, while Lupin will be the ...

Posttraumatic stress disorder in veterans with HIV increases the risk for AIDS and multiple chronic conditions, especially in ...

People with one of more than 20 breathing conditions could be eligible for up to £749 a month from the Department for Work ...

Mumbai: Global pharma major Lupin Limited has signed a supply and license agreement with Sino Universal Pharmaceuticals (SUP) ...

Plenty folk have an asthma puffer but few seem to know how to use it. Adherium says its Hailie device is improving compliance ...

New Partnership with Leonard Nimoy’s Daughter Aims to Raise COPD Awareness ...

A 6-minute walk of less than 350 meters tripled the mortality risk, whereas chronic kidney disease (CKD) independently ...

Lupin partners with SUP to commercialize Tiotropium DPI in China, aiming to improve respiratory health with innovative products.

as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD). Nucala stands out as the only approved biologic that has been ...